All Type of News


New pharmacists hardly find jobs

The IMF economic crisis hit a heavy blow to the recruitment of new pharmacists in pharmaceutical industry. Most of company announced their freezing policy in new employment of pharmacists and reducing number ...

Strategic tie-up between yuhan and Dong-A

3-year's 10 billion Won investment for development of an anti-osteoporosis drug. Two leading pharmaceutical companies, Yuhan (Representative: Kim Sun-jin) and Dong-A (Representative: Yu Choong-shik) ag...

KPhA nominated 7 vice presidents

7 Vice presidents, Mr. Moon Woong-dae, Mr. Ju Sang-jae, Ms. Park Jung-ja, Mr. Kim Ku, Mr. Moon Jae-bin, Mr. Kim Kwang-ki and Mr. Kim Jae-ho were newly appointed on Mar. 5th. KPhA also nominated Mr. Won Hee-mok a...

PROFILE OF MOHW VICE MINISTER. CHOI SUN-JUNG

New vice minister of health and welfare was nominated to Mr. Choi Sun-Jung who started his government administrative career after he passed the 10th national examination for high civil service in 1971. He se...

PROFILE OF KFDA HEAD, PARK JONG-SAE

The KFDA was recently separated from the MOHW and organized with enlarged structure. The first Administrator was appointed to Dr. Park Jong-Sae, the former head of the Toxicology Research Institute, which was som...

Profile of KIM HEE JUNG, new president of Korea Pharm. Assoc.

Mr. Kim Hee Jung was elected as the 31th President of Korea Pharmaceutical Association. They said He was combined with both of soft and rigid sides in his personality. He is well rounded in human relat...

Profile of new MOHW minister, JOO YANG-JA

Dr. Joo Yang Ja (67) was nominated as the 35th Minister of the MOHW. She, as a medical doctor, has vigorously carried out social as well as political activities in the National Assembly, and was listed on t...

Management target focused by major pharm.

The leading company executives put the profitability and cash procurement with the most priority on their management target under the IMF financial crisis, it was found in our recent interviews. To acco...

Amicable M&A possibility exposed to multinational corporation

Korea government eliminated restrictive provisions in stock markets, allowing foreigners to purchase up to 55% shares of a domestic firm, which provides many ossibilities for domestic pharmaceutical companies ...

The MOHW set 14,500 M. Won Subsidy for a New Drug R&D.

The lst meeting of Health Medical Technology Policy Deliberation Committee of the MOHW set 14,500 M. Won Subsidy for a New Drug R&D. According to the government subsidy plan for the R&D in the health med...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.